Characterizing Cancers: Utilizing IHC Panels to Identify Tumors of Unknown Primary Sites
The use of a curated selection of antibodies to target protein characteristics of distinct cell lineages has been in practice in clinical laboratories for many years. The ability for pathologists to identify cells of unknown origin via the use of Immunohistochemistry (IHC) is extremely important to aid in the diagnosis, treatment, and prognosis for their patients. This White Paper shows some of the commonly used IHC panels to help differentiate cells of unknown origin.
Download: Characterizing Cancers: Utilizing IHC Panels to Identify Tumors of Unknown Primary SitesFree White Paper Download!
![Colon cancer stained with Pan Cytokeratin [AE1/AE3] antibody.](https://biocare.net/wp-content/uploads/011-2-247x296.jpg)
Breast
25ml
25ml
Liver
25ml
intelliPATH Antibodies
25ml
Bladder
![Colon cancer stained with SATB2 [CL0323] antibody](https://biocare.net/wp-content/uploads/3259-SATB2-247x296.jpg)
Colon
intelliPATH Antibodies
intelliPATH Antibodies
25ml
Ovarian
Bladder
Cervical